Broadwood opposes revised STAAR Surgical acquisition by Alcon
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Broadwood Partners Responds to Alcon’s Increase to Proposed Acquisition Price of STAAR Surgical
December 9, 2025 12:39 PM ESTNotes That Price Bump Is Further Evidence That the Original Sale Process Was Horribly Flawed and Failed to Maximize Shareholder Value
New Price Is Approximately Half the Price Offered by Alcon Twice in 2024; STAARs Projections Have Not Changed Materially
Continues to Urge STAAR Shareholders to Vote AGAINST the Proposed Transaction
NEW YORK--(BUSINESS WIRE)-- Broadwood Partners, L.P. and its affiliates (collectively, Broadwood, we, us or our) today responded to the amended transaction terms of the proposed acquisition of STAAR Surgical Company (STAAR or the Company) (NASDAQ:... More
